US20030166236A1 - Modified xylanases exhibiting increased thermophilicity and alkalophilicity - Google Patents

Modified xylanases exhibiting increased thermophilicity and alkalophilicity Download PDF

Info

Publication number
US20030166236A1
US20030166236A1 US10/307,441 US30744102A US2003166236A1 US 20030166236 A1 US20030166236 A1 US 20030166236A1 US 30744102 A US30744102 A US 30744102A US 2003166236 A1 US2003166236 A1 US 2003166236A1
Authority
US
United States
Prior art keywords
trx
xylanase
amino acid
hml
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/307,441
Other languages
English (en)
Inventor
Wing Sung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Original Assignee
National Research Council of Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council of Canada filed Critical National Research Council of Canada
Assigned to NATIONAL RESEARCH COUNCIL OF CANADA reassignment NATIONAL RESEARCH COUNCIL OF CANADA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SUNG, WING L.
Publication of US20030166236A1 publication Critical patent/US20030166236A1/en
Priority to US11/377,644 priority Critical patent/US7695947B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/248—Xylanases
    • C12N9/2482—Endo-1,4-beta-xylanase (3.2.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)

Definitions

  • the present invention relates to modified xylanases. More specifically, the invention relates to modified xylanases with improved performance at conditions of high temperature and pH.
  • Xylanases are a group of enzymes with wide commercial utility. A major application of xylanases is for pulp biobleaching in the production of paper. In addition, xylanases have been used as clarifiing agents in juices and wines, as enzymatic agents in the washing of precision devices and semiconductors (e.g. U.S. Pat. No. 5,078,802), and they are also used for improving digestibility of poultry and swine feed.
  • pulping In the manufacturing of pulp for the production of paper, fibrous material is subjected to high temperatures and pressures in the presence of chemicals. This treatment converts the fibers to pulp and is known as pulping. Following pulping, the pulp is bleached. Xylanase enzymes are used to enhance the bleaching of the pulp. The xylanase treatment allows subsequent bleaching chemicals such as chlorine, chlorine dioxide, hydrogen peroxide, or combinations of these chemicals to bleach pulp more efficiently. Pretreatment of pulp with xylanase increases the whiteness and quality of the final paper product and reduces the amount of chlorine-based chemicals which must be used to bleach the pulp. This in turn decreases the chlorinated effluent produced by such processes.
  • the most important chemical pulping process is kraft pulp.
  • kraft pulp following pulping, and prior to the treatment of pulp with xylanase, the pulp is at about a temperature of 55-70° C. and at a highly alkaline pH (e.g. Nissen et al., 1992).
  • a drawback of many commercially available wild-type xylanases is that these enzymes exhibit an acidic pH optimum and a temperature optimum of about 55° C. Therefore, in order to effectively utilize xylanases for bleaching applications, the pulp must be acidified to a pH approximating the optimal pH for the specific xylanase used.
  • the hot pulp must be cooled to a temperature close to the optimal temperature for enzymatic activity of the selected xylanase.
  • Decreasing pulp temperatures for xylanase treatment decreases the- efficiency of the subsequent chemical bleaching.
  • Acidification of pulp requires the use of large quantities of acids. Further, the addition of acids leads to corrosion, which lessens the lifetime of process equipment.
  • xylanases optimally active at temperatures and pH conditions approximating the conditions of the pulp would be useful and beneficial in pulp manufacturing.
  • Xylanases which exhibit greater activity at higher temperatures could be used to treat pulp immediately following the pulping process, without the need to cool the pulp. Similarly, xylanases which exhibit greater activity at higher pH conditions would require less or no acid to neutralize the pulp.
  • the isolation of, or the genetic manipulation of, xylanases with such properties would provide several advantages and substantial economic benefits within a variety of industrial processes.
  • thermostable xylanases from extreme thermophiles that grow at 80-100° C., such as Caldocellum saccharolyticum, Thermatoga maritima and Thermatoga sp. Strain FJSS-B. 1 (Lüthi et al. 1990; Winterhalter et al. 1995; Simpson et al. 1991).
  • thermostable xylanase enzymes are large, with molecular masses ranging from35-120 kDa (320-1100 residues), and exhibit a reduced ability to penetrate the pulp mass compared with other smaller xylanases which exhibit better accessibility to pulp fibers.
  • some of the extremely thermophilic xylanases such as Caldocellum saccharolyticum xylanase A, exhibit both xylanase and cellulase activities (Lüthi et al. 1990). This additional cellulolytic activity is undesirable for pulp bleaching, due to its detrimental effect on cellulose, the bulk material in paper.
  • hyper-thermostable xylanase enzymes which function normally at extremely high temperatures have low specific activities at temperatures in the range for optimal pulp bleaching (Simpson et al. 1991).
  • U.S. Pat. No. 5,405,769 discloses modification of Bacillus circulans xylanase (BOX) using site-directed mutagenesis to improve the thermostability of the enzyme.
  • the site specific mutations include replacing two amino acids with Cys residues to create intramolecular disulfide bonds.
  • specific residues in the N-terminus of the enzyme were mutated which were also found to further improve the thermostability of the enzyme.
  • the disulfide mutants showed thermostability at 62° C., an improvement of 7° C. over the native BcX xylaaase enzyme.
  • thermostable disulfide mutants showed no gain in thermophilicity in laboratory-assays in subsequent studies (Wakarchuck et al., 1994). Mutations T3G (i.e. threonine at position 3 replaced with Gly; BcX xylanase amino acid numbering), D4Y(F) and N8Y(F) near the N-terminus of the BcX xylanase enzyme provided thermostability to 57° C., an increase of 2° C. over the native BcX (U.S. Pat. No. 5,405,769). However, the use of these enzymes within industrial applications still requires cooling and acidification of pulp following pretreatment, prior to enzyme addition. Therefore, further increases in thermostability, thermophilicity and pH optima are still required.
  • the present invention relates to modified xylanases. More specifically, the invention relates to modified xylanases with improved performance at conditions of high temperature and pH.
  • This invention relates to a modified xylanase comprising at least one substituted amino acid residue at a position selected from the group consisting of amino acid 75, 104, 105, 125, 129, 132, 135, 144, 157, 161, 162, and 165 the position determined from sequence alignment of the modified xylanase with Trichoderma reesei xylanase II amino acid sequence defined in SEQ ID NO:16.
  • the modified xylanase exhibits improved thermophilicity, alkalophilicity, or a combination thereof, in comparison to a corresponding native xylanase.
  • the present invention also provides for the modified xylanase as defined above wherein the at least one substituted amino acid residue is at position 75.
  • the substituted amino acid is selected from the group consisting of Ala, Cys, Gly, and Thr.
  • the present invention also embraces modified the modified xylanase as defined above and further comprising a His at position 10, Met at position 27 and Leu at position 29.
  • a modified xylanase comprising a substituted amino acid residue at position 105, the position determined from sequence alignment with Trichoderma reesei xylanase II amino acid sequence defined in SEQ ID NO:16.
  • the substituted amino acid is selected from the group consisting of His. Lys, and Arg.
  • the present invention also pertains to the modified xylanase just defined further comprising a His at position 10, Met at position 27 and Leu at position 29.
  • the invention also includes the modified xylanase just defined further comprising a substituted amino acid residue at position 75.
  • This invention also includes a modified xylanase comprising a Lis at position 10, a Met at position 27, a Leu at position 29, a non-polar amino acid at positions 75 and 125,; a non-polar amino acid at positon 104, a polar amino acid at position 105, and an acidic amino acid at position 129.
  • the amino acid at postion 75 is Ala
  • the amino acid at position 125 is selected from.the group consistig of Ala, Cys, Gly, and Thr
  • the amino acid at position 25 is Glu.
  • the amino acid at position 105 is selected from the group consisting of His, Lys, and Arg
  • the amino acid residue at position 104 is Pro.
  • This invention further relates to a modified xylanase comprising a His at position 10, a Met at position 27, a Leu at position 29, a non-polar amino acid at positions 75 and 125, a polar amino acid at positions 105, 132 and 135, and an acidic amino acid at position 129.
  • the modified xylanase as just defined may include a polar amino acid at position 44.
  • This invention includes a modified xylanase comprising a His at position 10, a Met at position 27, a Leu at position 29, a non-polar amino acid at positions 75 and 125, a polar amino acid at positions 105, 132, 135, 144, 157, 161, 162 and 165, and an acidic amino acid at position 129.
  • This invention embraces a modified xylanase comprising a His at position 10, a Met at position 27, a Leu at position 29, a non-polar amino acid at positions 75 and 125, a polar amino acid at positions 105, 132, 135, 157, 161, 162 and 165, and an acidic amino acid at position 129.
  • This invention also pertains to a modified xylanase comprising a His at position 10, a Met at position 27, a Leu at position 29, a non-polar amino acid at positions 75 and 125, and a polar amino acid at positions 105, 135, 144, 157, 161, 162and 165.
  • the present invention is also directed to the modified xylanases, as defined above, wherein the modified xylanases are derived from a Family 11 xylanase, preferably a Trichoderma reesei xylanase.
  • the present invention pertains to a modified xylanase comprising at least one substituted amino acid residue, wherein the modified xylanase is characterized-as having a maximum effective temperature (MET) between about 69° C. to about 78° C., and wherein the modified xylanase is a Family 11 xylanase obtained from a Trichoderma sp.
  • MET maximum effective temperature
  • the MET is between about 70° to about 75° C.
  • This invention also includes a modified xylanase comprising at least one substituted amino acid residue, wherein the modified xylanase is characterized as having a maximum effective pH (MEP) between about pH 5.8 to about pH 7.6, and wherein the modified xylanase is a Family 11 xylanase obtained from a Trichoderma sp.
  • MEP maximum effective pH
  • the MEP is between about pH 6.5 to about pH 7.4.
  • the present invention is directed to a modified xylanase comprising at least one substituted amino acid residue, wherein the modified xylanase is characterized as having a maximum effective temperature (MET) between about 69° C. to about 78° C., and a maximum effective pH (MEP) between about pH 5.8 to about pH 7.6.
  • MET maximum effective temperature
  • MEP maximum effective pH
  • the MET is between about 70° to about 75° C.
  • the MEP is between about pH 6.5 to about pH 7.4.
  • the present invention also relates to a modified xylanase selected from the group consisting of:
  • TrX-HML-75A-105R [0033] TrX-HML-75A-105R;
  • TrX-HML-75C-105R TrX-HML-75C-105R
  • TrX-HML-75G-105R TrX-HML-75G-105R
  • TrX-H 125A-129E [0038] TrX-H 125A-129E;
  • TrX-HML-75G-105R-125A-129E TrX-HML-GRAE
  • TrX-HML-75A-105H-125A-129E TrX-HML-AHAE
  • TrX-HML-75G-105H-125A-129E TrX-HNML-GHAE
  • TrX-HML-75A-105R-125A-129E TrX- ML-ARAE
  • TrX-HML-75G-104P-105R-125A-129E TrX-HML-GPRAE
  • TrX-HM h75G-104P-105H-125A-129E TrX-HML-GPHAE
  • TrX-HML-AHAE-RRR-DRHH TrX-HML-AHAE-RRR-DRHH
  • TrX-HMLAHA-RR-DREH TrX-HMLAHA-RR-DREH
  • TrX-HML-AHAE-RR-DRHH TrX-HML-AHAE-RR-DRHH.
  • a modified xylanase comprising at least one substituted amino acid residue, and characterized as having a maximum effective temperature (MEI) between about 69° C. to about 78 ° C.
  • the modified xylanase is a Family 11 xylanase obtained from a Trichoderma sp.
  • the present invention relates to a modified Family 11 xylanase obtained from a Trichoderma sp. characterized as having a MET between about 70° to about 75° C.
  • the present invention also includes the modified Family 11 xylanase obtained from a Trichoderma sp. characterized as having a MET between about 69° C. to about 78° C. and a maximum effective pH (EP) between about 5.8 to about 7.6.
  • This invention also pertains to the modified xylanase as just defined, wherein the MEP is between about 6.5 to about 7.4.
  • the present invention is directed to the use of the modified- xylanase as defined above in an industrial process. Also included is an industrial process, wherein the industrial process comprises bleaching of pulp, processing of precision devices, or improving digestibility of poultry and swine feed.
  • FIG. 1 shows an amino acid sequence alignment among Family 11 xylanases.
  • the amino acid numbering is compared with Trichoderma ressei xylanase II (Tr2) as indicated at the top of the sequences.
  • the residues at position 75 and 105 are in italic and indicated with an asterisk.
  • the amino acids common to at least 75% of the listed Family 11 xylanases are indicated in bold.
  • the residues common to all Family 11 xylanases are underlined. For xylanases with a cellulose-binding domain, only the catalytic core sequences are presented.
  • FIG. 2 shows the nucleotide sequence of TrX xylanase (SEQ ID NO:39), and the synthetic oligonucleotides used to construct the sequence encoding the Trichoderma reesei xylanase II enzyme (TrX) in the plasmid pTrX.
  • FIG. 3 shows the effect of temperature on the enzymatic activity of modified xylanase TrX-75A, compared with TrX, at pH 5.5 during 30 min incubations. The data are normalized to the activity observed at 40° C.
  • FIG. 4 shows the effect of temperature on the enzymatic activity of modified xylanases TrX-HML, TrX-HML-75A, TrX-HML-105H and TrX-HML-75A-105H, at pH 5.5 during 30 min incubations. The data are normalized to the activity observed at 40° C.
  • FIG. 5 shows the effect of temperature on-the enzymatic activity of modified xylanases TrX-HL,TrX-1ML-105K,TrX-HL105R,TrX-HML105H,TrX-HML-75A-105R and TrX-HML-75A-105H at pH 5.5 during 30min incubations. The data are normalized to the activity observed at 40° C.
  • FIG. 6 shows the effect of temperature on the enzymatic activity of modified xylanases TrX-HML, TrX-HML-105R, TrX-HML-75T-105R, TrX-L 75G-105R, TrX-HML 75A-105R and TrX-HML-75C-105R at pH 5.5 during 30 nun incubations. The data are normalized to the activity observed at 40° C.
  • FIG. 7 shows the effect of temperature on the enzymatic activity of modified xylanase enzyme TrX-HML, TrX-HML-125A, TrX-HML-125A129E and TrX-HML 75G-105R-125A129E (TrX-HML-GRAE) at pH 5.5 during 30 rmin incubations. The data are normalized to the activity observed at 40° C.
  • FIG. 8 shows the effect of temperature on the enzymatic activity of modified xylanase enzymes:
  • TrX-HML 105H [0063] TrX-HML 105H;
  • TrX-HML-75A-10SH-125A129E (TrX-HML-AHAE);
  • TrX-HlML-75G-105H-125A129E TrX-B GHAE
  • TrX-75A-105R-125A129E TrX-HML-ARAE
  • FIG. 9 shows the effect of temperature on the enzymatic activity of modified xylanase, enzymes:
  • TrX-HML-75G-104P-105R-125A129E TrX-HML-GPRAE
  • TrX-HML-75G-104P-105H-125A129E TrX-HML-GPHARE
  • TrX-HML-75G-105R-125A129E TrX-HML-GRAE
  • FIG. 10 shows the pH profile of modified xylanase enzyme TrX-75A compared with native TrX, over pH 4.0-6.5, at. 55° C. during 30 min incubation. The data are normalized to the pH exhibiting optimal activity for each enzyme.
  • FIG. 11 shows the pH profiles of modified xylanases TrX-HML, TrX-HML-75A, TrX-HML-105H and TrX-HML-75A-105H over ph 4-7, at 65° C. during 30 min incubation. The data are normalized to the pH exhibiting optimal activity for each enzyme.
  • FIG. 12 shows the pH profile of modified xylanases TrX-HML, TrX-HML-105K, TrX-HML-105R, TrX-HML-105H and TrX-HML-75A-105H over pH 4-7, at 65° C. during 30 min incubation. The data are normalized to the pH exhibiting optimal activity for each enzyme.
  • FIG. 13 shows the pH profile of modified xylanases:
  • TrX-HLM-105R TrX-HLM-105R
  • TrX-HML-75T-105R TrX-HML-75G-105R
  • TrX-HML-75A-105R [0080] TrX-HML-75A-105R;
  • FIG. 14 shows the pH profile of modified xylanases:
  • TrX-HML-75A-105H TrX-HML-75A-105H
  • TrX-HML-75A-105H-125A129E TrX-HML-AHAE
  • TrX-HML-75G-105H-125A129E TrX-HML-GHAE
  • FIG. 15 shows the effect of temperature on the enzymatic activity of modified xylanase TrX-157D-161R-162H-165H, compared with TrX, at pH 5.5 during 30 min incubations. The data are normalized to the activity observed at 40° C.
  • FIG. 16 shows the pH profile of modified xylanase enzyme TrX-1 57D-161R-162H-165H compared with native TrX, over pH 4.0-6.5, at 55° C. during 30 min incubation. The data are normalized to the pH exhibiting optimal activity for each enzyme.
  • FIG. 17 shows the effect of temperature on the enzymatic activity of modified xylanases:
  • FIG. 18 shows the effect of temperature on the enzymatic activity of modified xylanases:
  • TrX-HML-AHA-RR-DRHH TrX-HML-AHA-RR-DRHH
  • TrX-HML-AHAE-RR-DRHH TrX-HML-AHAE-RR-DRHH
  • FIG. 19 shows the effect of temperature on the enzymatic activity of modified xylanases:
  • TrX-HML-AHA-RR-DRHH TrX-HML-AHA-RR-DRHH
  • FIG. 20 shows the maximum effective temperature (MET) and maximum effective pH (MEP) values of several of the modified enzymes of the present invention
  • the MET and MEP are the highest temperature and pH, respectively, at which a xylanase exhibits at least 80% of its optimal activity (using xylanase substrate; see method for complete details of assays).
  • the present invention relates to modified xylanases. More specifically, the invention relates to modified xylanases with improved performance at conditions of high temperature and pH.
  • xylanases facilitate bleaching of pulp. It has been postulated that the coloured lignin is connected to crystalline cellulose through xylan and xylanase enzymes facilitate bleaching of pulp by hydrolysing xylan, releasing coloured lignin in the pulp. Modified xylanases, as outlined herein, may be used for the purposes of bleaching pulp or other applications requiring activities at temperatures and pH above that of the wild-type enzyme.
  • the preferred xylanase is derived from a xylanase classified in Family 11 (see Table 1), however, the modifications disclosed herein need not be limited to only Family 11 xylanases and may include other xylanase enzymes.
  • Family 11 xylanase enzymes are a group of small enzymes of relatively low molecular mass (approximately 20 kDa, and about 200 amino acid residues. The small size associated with Family 11 xylanases permits ready penetration of the pulp mass. Furthermore, Family 11 xylanases are free of cellulase activity.
  • One aspect of the present invention is directed to a modified Family 11 xylanase obtained from a Trichoderma sp. comprising at least one substituted amino acid residue, and characterized as having a maximum effective temperature (ET) between about 69° C. to about 78° C.
  • the modified xylanase is characterized as having a MET between about 70° to about 75° C.
  • This invention also includes a modified xylanase comprising at least one substituted amino acid residue, and is characterized as having a maximum effective pH SEP) between about 5.8 to about 7.6.
  • the MEP is between about 6.5 to about 7.4.
  • This invention also pertains to a modified xylanase obtained from Trichoderma, comprising at least one substituted amino acid, and characterized as having a maximum effective temperature (MET) between about 69° C. to about 78° C., and a maximum effective pH (MEP) is between about 5.8 to about 7.6.
  • MET maximum effective temperature
  • MEP maximum effective pH
  • the MET is between about 70° to about 75° C.
  • the MEP is between about 6.5 to about 7.4.
  • maximum effective temperature or “MET” it is meant the highest temperature at which a xylanase exhibits at least 80% of its optimal activity. This test is typically carried out using xylan as a substrate at pH 5.5, and for a 30 min period. Results from assays used to characterize modified xylanases are presented in FIGS. 3 to 9 and involved a 30 min incubation at pH 5.5. A summary of the MET of several enzymes of the present invention, determined from FIGS. 3 to 9 is presented in FIG. 20. Experiments demonstrate that the MET of a xylanase differs on different substrates. Therefore, it is to be understood that with different substrates, different MET values will be obtained (data not presented). For the purposes of evaluating xylanases of the present invention, the xylan substrate is used (see examples 3 and 4).
  • maximum effective p1 or “MEP” it is meant the highest pH at which a xylanase exhibits at least 80% of its optimal activity. This test is carried out using xylan as a substrate, at 65 ° C., and for a 30 min period. Results from assays-used to characterize modified xylanases are presented in FIGS. 10 to 14 and 16 to 19 and involved a 30 min incubation at 65° C. A summary of the MEP of several enzymes of the present invention is presented in FIG. 20. Experiments demonstrate that the MEP of a xylanase differs on different substrates.
  • the xylan substrate is used (see examples 4 and 5).
  • Xyn Clostridium acetobutylicum Xyn B SEQ ID NO: 6 Clostridium stercorarium Xyn A SEQ ID NO: 7 Fibrobacter succinognees Xyn II SEQ ID NO: 18 Neocallimasterix patriciarum Xyn A — Nocardiopsis rougevillei Xyn II — Ruminococcus flavefaciens Xyn A SEQ ID NO: 8 Schizophyllum cimmune Xyn SEQ ID NO: 9 Streptomyces lividans Xyn B SEQ ID NO: 10 Streptomyces lividans Xyn C SEQ ID NO: 11 Streptomyces sp. No.
  • Family 11 xylanases share extensive amino acid sequence similarity (FIG. 1). Structural studies of several Family 11 xylanases indicate that Family 11 xylanases from bacterial and fungal origins share the same general molecular structure U.S. Pat. No. 5,405,769; Arase et al 1993). In addition, most Family 11 xylanases identified so far exhibit three types of secondary structure, including beta-sheets, turns and a single alpha helix. The helix of Trichoderma reesei xylanase II enzyme encompasses the region from amino acid 151 to amino acid 162 (Torronen et. al. 1995).
  • a xylanase is classified as a Family 11 xylanase if it comprises amino acids common to other Family 11 xylanases, including two glutamic acid (E) residues which may serve as catalytic residues.
  • the glutamic acid residues are found at positions 86 and 177 (see FIG. 1; based on Tr2 ( Trichoderma reesei xylanase II enzyme) amino acid numbering).
  • thermostable xylanases of higher molecular mass, Thermomonospora fusca xylanase A (Tfx-A) of 296 amino acids and a molecular mass of approximately 32 kDa (h-win et. al., 1994); Wilson et al. 1994, WO 95/12668) and Clostridium stercorarium xylanase A of 511 amino acids and a molecular mass of approximately 56 Kda.
  • the Clostridium stercorarium xylanase A enzyme exhibits maximum activity at a temperature of 70° C. (Sakka et al., 1993).
  • the large thermostable Family 11 xylanases differ from the small mesophilic enzymes by the possession of a hydrophobic cellulose-binding domain (CBD) in the extended C-terminus of the enzyme.
  • CBD hydrophobic cellulose-binding domain
  • the TFX-A enzyme is composed of a catalytic core sequence of 189 residues common to all Family 11 xylanases, and a cellulose binding domain of 107 residues.
  • the larger C. stercorarium xylanase A has 2 copies of the cellulose binding domain.
  • mutant xylanase is one derived from a Family 11 xylanase. More preferably, the mutant xylanase of the present invention comprises a mutant Trichoderma reesei xylanase II enzyme.
  • xylanases including Family 11 xylanases for example but not limited to Trichoderma reesei xylanase II, Trichoderma reesei xylanase I, Trichoderma viride xylanase, Streptomyces lividans xylanase B and Streptoinyces lividans xylanase C, maybe modified following the general approach and methodology as outlined herein.
  • non-Family 11 xylanases may also be modified following the general principles as described herein in order to obtain a xylanase enzyme that exhibits thermophilicity and alkalophilicity.
  • thermophilicity it is meant that an enzyme is active, or more active, at a higher temperature when compared with the activity of another enzyme when all other conditions remain constant.
  • xylanase 1 exhibits increased thermophilicity compared to xylanase 2 if xylanase 1 is capable of, or is more active in, hydrolysing xylan at a higher temperature than xylanase 2, under identical conditions using the same substrate.
  • xylanases are effective at a higher temperature when hydrolysing pure xylan rather than pulp, comparative analysis should be made using the same substrate. Quantitative measures of thermophilicity referred to herein use pure xylan substrates unless otherwise indicated.
  • thermostability it is meant the ability of an enzyme to be stored or incubated at high temperature conditions, typically in the absence of substrate, and then exhibit activity when returned to standard assay conditions.
  • xylanase 1 is said to display increased thermostability compared to xylanase 2 if xylanase 1 retains a greater amount of activity than xylanase 2 after being maintained at a certain temperature (typically a higher temperature), for example but not limited to, 70° C. for 24 hours, followed by assay at a lower temperature.
  • thermostability relates to the remaining enzyme activity following an incubation in the absence of substrate.
  • alkalophilicity it is meant that an enzyme is active, or more active, at a higher pH when compared with the activity of another enzyme when all other conditions remain constant.
  • xylanase 1 exhibits increased alkalophilicity compared to xylanase 2 if xylanase 1 is capable of hydrolysing xylan at a higher pH than xylanase 2.
  • alkalophilicity relates to enzyme activity in the presence of xylan substrate.
  • TrX numbering it is meant the numbering associated with the position of amino acids based on the amino acid sequence of TrX (Xyn II-Table 1; Tr2-FIG. 1; SEQ ID NO:16). As disclosed below and as is evident upon review of FIG. 1, Family 11 xylanases exhibit a substantial degree of sequence similarity. Therefore, by aligning the amino acids to optimize the sequence similarity between xylanase enzymes and by using the amino acid numbering of TrX as the basis for numbering, the positions of amino acids within other xylanase enzymes can be determined relative to TrX.
  • modified xylanase it is meant the alteration of a xylanase molecule using techniques that are known to one of skill in the art. These techniques include, but are not limited to, site directed mutagenesis, cassette mutagenesis, random mutagenesis, synthetic oligonucleotide construction, cloning and other genetic engineering techniques.
  • mutant xylanases have been prepared that exhibit increased thermophilicity; alkalophilicity arid thermostability when compared to native xylanase.
  • the present is directed to a modified Family 11 xylanase obtained from a Trichoderma sp. that comprises at least one substituted amino acid residue, and characterized as having a maximum effective temperature (UMT) between about 69° C. to about 78 ° C.
  • UAT maximum effective temperature
  • the modified xylanase is characterized as having a MET between about 70° to about 75 ° C.
  • MEP maximum effective pH
  • the MEP is between about 6.5 to about 7.4.
  • This invention also pertains to a modified xylanase obtained from Trichoderma, comprising at least one substituted amino acid, and characterized as having a maximum effective temperature (MET) between about 69° C. to about 78° C., and a maximum effective pH (MEP) is between about 5.8 to about 7.6.
  • MET maximum effective temperature
  • MEP maximum effective pH
  • the MET is between about 70to about 75° C.
  • the MEP is between about 6.5 to about 7.4.
  • TrX-75A bearing a single S75A mutation, showed greater enzymatic activity than the native TrX xylanase at 50, 55, 60 and 65° C. (FIG. 3). Further, the S75A mutation in the TrX-E75A mutant xylanase exhibited greater enzymatic activity than the TrX-HML parent xylanase at 70° C. and 75° C. (FIG. 4). These results suggest that the S75A mutation improves the thermophilicity of TrX and TrX-HML xylanases.
  • the Ser to Ala mutation at position 75 improves the thermophilicity for both TrX-75A and TrX-HML75A xylanases in comparison to their native counterparts.
  • the S75A mutation represents a change from a Ser amino acid bearing a side-chain which is relatively polar and hydrophilic to an Ala residue which bears a small and relatively nonpolar side-chain.
  • replacing the polar serine amino acid with the smaller nonpolar Ala residue enhances intramolecular packing of the xylanase.
  • the enhanced intramolecular packing of the tertiary structure of xylanase may in turn improve van der Waals interactions between closely positioned apolar substituents.
  • the result of such improved intramolecular packing is an increase in the thermophilicity of the enzyme. In such cases, higher temperatures are required to denature and inactivate the mutant xylanase.
  • Substitution of position 157 with an acidic amino acid, and positions, 161, 162, and 165 with a basic amino acid for example, but not limited to, replacing Asn at 157 with Asp (N157D, Ala at position 161 with Arg (A161R), Gln at position 162 with His (Q162H), and Thr at position 165 with His (T165H) to produce TrX-157D-161R-162H-165H may result in a slight increase in the thermophilicity of this enzyme over that of the parent TrX enzyme (FIG. 15).
  • TrX-HML xylanase mutation of Leu 105 to His (L105H) in TrX-HML xylanase to produce the TrX-HML-105H mutant xylanase exhibits increased enzymatic activity over the parent TrX-HML xylanase at 70 and 75° C. (FIG. 4).
  • the Leu to His mutation at position 105 improves the thermophilicity of TrX-HML-105H in comparison to TrX-HML xylanase.
  • the L105H mutation represents a change from Leu, which is a hydrophobic, branched-chain amino acid to His bearing a relatively bulky, polar imidazole side-chain.
  • the L105H mutation introduces a reasonably bulky, planar amino acid capable of hydrogen bonding with other amino acids in the same vicinity of the molecule, possibly enhancing the intramolecular packing of atoms in the enzyme and thereby stabilizing the tertiary structure of the enzyme.
  • the imidazole side-chain may be protonated in the assay conditions to give the conjugate acid of imidazole.
  • the protonated imidazole moiety may partake in attractive electrostatic interactions within the three dimensional tertiary structure of the xylanase and thereby stabilize its tertiary structure.
  • TrX-HML-75A-105H The combined mutant xylanase, TrX-HML-75A-105H, exhibited a maximum enzymatic activity at a temperature of 70° C. and further showed greater enzymatic activity than either TrX-HML-75A or TrX-HML-105H single mutant xylanases at 70° C. (FIG. 4).
  • TrX-HML xylanases bearing mutations at position-105 were constructed to determine those amino acid residues which enhance the thermophilicity of the parent TrX-HML enzyme (FIG. 5). Three mutants at position 105, TrX-HML-105H, TrX-HML-105R and TrX-HML-105K, showed greater enzymatic activity than the precursor TrX-HML enzyme from about 60° C or higher.
  • the native xylanase comprises a Leu at position 105, a relatively hydrophobic branched-chain amino acid.
  • Mutant xylanases wherein position 105 is substituted with a hydrophilic, positively charged or basic amino acid, for example His, Arg or Lys exhibited enhanced thermophilicity.
  • TrX-HML-75A-105R xylanase showed a similar temperature-activity profile to TrX-HML75A-105H xylanase, suggesting that the S75A and L105R mutations, like those of the S75A and L105H mutations are additive or complementary. These results further suggest that basic residues at position 105 enhance the thermophilicity of the xylanases.
  • TrX-HML-75C-105R Three genetically modified xylanase mutants, TrX-HML-75C-105R, TrX-HML-75A-105R and TrX-HML-75G-105R showed greater enzymatic activity than either the precursor TrX-HML 105R xylanase or the TrX-HML xylanase at temperatures greater than about 60° C. (FIG. 6).
  • a fourth mutant TrX-HML-75T-105R xylanase showed no enhancement in thermophilicity over the precursor TrX-HML-105R xylanase that has a natural Ser residue at position 75.
  • the mutant threonine residue at position 75 like the natural Ser 75 residue found in TrX and TrX-HML parent xylanases, is a hydrophilic amino acid.
  • the mutations which involve replacing Ser at position 75 with small, nonpolar amino acids, such as but not wishing to be limiting Ala, Gly or Cys lead to an increase in the thermophilicity of the xylanase.
  • a series of mutant xylanases were also constructed with mutations Gln-125 to Ala and Ile-129 to Glu.
  • the new mutants showed an increase of enzymatic activity at higher temperatures, as compared to their precursor xylanases (see FIGS. 7 to 9 ). These include (see Table 2 for complete description of modified enzymes):
  • TrX-HML-GRAE TrX-HML-GRAE
  • TrX-HML AHAE TrX-HML AHAE
  • TrX-HML-GHAE TrX-HML-GHAE
  • TrX-HML ARAE [0153] TrX-HML ARAE
  • the expression and recovery of these modified xylanases may be reduced or not possible due to the synthesis of sites within the protein that reduce expression or recovery of the modified xylanase.
  • This reduced recovery may vary depending upon the host within which the modified enzyme is expressed.
  • alterations of the amino- acid sequence may produce a proteolytic cleavage site that is recognized by a protease in certain, but not all hosts.
  • adjacent amino acids on one or both sides of the site comprising the desired mutation, may be modified in order to attend to any host-specific difficulty for the expression and recovery of a modified xylanase.
  • the additional amino acids that are altered do not negate the effect of the initially substituted amino acid in increasing the thermophilicity, or alkalophilicity, or both the thermophilicity and alkalophilicity, of the enzyme.
  • a modified xylanase comprising a substitution of L105R, can be produced from E. coli, however, the recovery of this enzyme is reduced in Trichoderma, and Aspergillus due to endogenous KEX protease activity recognizing the amino acid combination “Lys-Arg” at positions 104 and 105 respectively.
  • the amino acid at position 104 may be substituted for by an alternate amino acid, for example a non-polar amino acid as in modified xylanses TrX-HML-GPHAE, or TrX-HML-GPRAE.
  • an alternate amino acid for example a non-polar amino acid as in modified xylanses TrX-HML-GPHAE, or TrX-HML-GPRAE.
  • the substitution of Lys at position 104by Pro does not affect the thermophilicity or alkalophilicity of these modified xylanase.
  • the present invention also pertains to a modified xylanase comprising one or more substituted amino acids adjacent to the amino acids as described herein.
  • This invention therefore includes a modified xylanase comprising a His at position 10, a Met at position 27, a Leu at position 29, and at least one of:
  • the amino acid at position 75 is Ala
  • the amino acid at position 125 is selected from the group consisting of Ala, Cys, Gly, and Thr
  • the amino acid at position 125 is Glu
  • the amino acid at position 105 is selected from the group consisting of His, Lys, and Arg
  • the amino acid residue at position 104 is Pro.
  • TrX-75A The effect of pH conditions on the enzymatic activity of single mutant TrX-75A xylanase is shown in FIG. 10.
  • the TrX-75A mutant xylanase displays an increase in activity above pH 5.5 when compared to the native TrX enzyme over the same pH range.
  • a similar contribution to improved alkalophilicity by the substitution of Ser for Ala at position 75 (Trx-75A) was also observed for the TrX-HML-75A over the parent TrX-HML xylanase at pH conditions between 6.5 and 7 (FIG. 11).
  • TrX-157D-161R-162H-165H An increase in alkalophilicity, with an increase in activity over pH from about 5.2 to a pH of about 6.5 is also observed in TrX-157D-161R-162H-165H, when compared with that of the native TrX over the same pH range (FIG. 16).
  • TrX-HML-105H mutant xylanase also increased the enzymatic activity over the parent TrX-HML xylanase at pH 6.5 and 7.0 (FIG. 11).
  • the combination mutant TrX-HML-75A-105H xylanase showed greater enzymatic activity than either TrX-HML75A or TrX-HML-105H single mutant xylanases at pH 6.5 and 7.0 (FIG. 11), suggesting that the effects of the S75A mutation and the L105H mutation on the alkalophilicity of the xylanase are additive or complementary.
  • a series of genetically modified xylanases modified at position 105 were constructed to determine those residues which promote increased alkalophilicity in modified xylanases (FIG. 12).
  • Three mutant xylanases bearing three mutations at position 75, TrX-HML O-15H, TrX-HML-105R and TrX-HML-105K showed greater enzymatic activity than the precursor TrX-HML xylanase at pH conditions of6.5 and 7.0.
  • the mutations which lead to increases in alkalophilicity represent a change from a branched chain relatively hydrophobic Leu residue to a residue which is hydrophilic, positively charged or basic.
  • the hydrophilic, positively charged, or basic residues may facilitate intramolecular packing with other atoms that are juxtapositioned in the same vicinity in the tertiary structure of the xylanase. These residues may stabilize the three dimensional structure of the enzyme against structural perturbations in the molecule which may arise via the-titration of several ionizable side-chains of amino aids in other regions of the molecule.
  • the basic ionized form of the side chain may be important in altering the pH activity profile of the enzyme, as at pH conditions between 6 and 7, Arg and Lys residues have side-chains which likely remain protonated.
  • His residues having a pKa of approximately 6 in solution for its imidazole moiety could be present in either a protonated or unprotonated form.
  • the polarity of the substituents surrounding an amino acid side chain may affect its pKa value.
  • the side chain of a His residue in a polar or hydrophobic region of a protein may exhibit a pKa of 6 whereas the same side-chain in a hydrophobic or apolar environment may exhibit a pKa of 7 or greater.
  • the mutations Q125A and I29E that enhanced the thermophilicity of xylanases are compatible to the mutations at positions 75 and 105 described above, as the combination mutants like TrX-HML-75G-105H-125A129E possessing these two mutations generally maintained the pH activity profile of the precursor xylanase Trx- HML-75G-105H (FIG. 14).
  • a series of mutant xylanases were also constructed with mutations Gln-125 to Ala, and Ile-129 to Glu.
  • the new mutants showed an increase of enzymatic activity at higher pH, as compared to their precursor xylanases (see FIGS. 11 to 14 and 17 - 19 ). These include (see Table 2 for complete description of modified enzymes):
  • TrX-HML-125A [0171] TrX-HML-125A
  • TrX-HML-GRAE TrX-HML-GRAE
  • TrX-HML-GHAE TrX-HML-GHAE
  • TrX-HML-ARAE TrX-HML-ARAE
  • Trx-L-AHAE-RRR-DRHH [0181] Trx-L-AHAE-RRR-DRHH;
  • TrX-MLAHA-RR-DRHH TrX-MLAHA-RR-DRHH
  • TrX-HML-AHAE-RR-DRHH, or TrX-HML-AHAE-RRR-DRRH each exhibited an increase in alkalophilicity (FIGS. 18, 19) and a MEP of about 7.0 (FIG. 20), when compared with TrX-HML-AHAE, which comprises a MEP of about 6.5, or TrX, with a MEP of about 5.6.
  • the breadth of the pH optimum for TrX-HML-AHAE is much broader when compared to the pH profile of TrX (e.g. see FIG. 19).
  • Several of the modified xylanases of the present invention exhibit a breadth in the pH optimum approaching that of the breadth of native TrX, however, the pH optimum of these modified xylanases is shifted, with an increase of about at least 1 pH unit (FIG. 19) when compared to that of TrX.
  • TrX exhibits 80% of its optimal activity from about pH 4.8 to about pH 5.6 (H optimum at 80% activity over 0.8 pH units).
  • TrX-HAHAE exhibits a much broader pH range where 80% of its optimal activity ranges from about pH 4.8 to about pH 6.5 (about 1.7 pH units).
  • the range of 80% of optimal activity for TrX-HML-AHAE-RR and TrX-HML-AHAE-RRR is from about 5.4 to about 6.6 (about 1.2 pH units; FIG. 17)
  • TrX-HML-AHAE-RRR-DRHH and TrX-HML-AHAE-RR-DRHH is from about pH 5.8 to about 7.0 (about 1.2 pH units)
  • TrX-HML-AHA-RR-DRHH is from about 5.9 to about 7.4 (about 1.5 pH units; see FIGS. 18 and 19).
  • this invention also pertains to a modified xylanase comprising a His at position 10, a Met at position 27, a Leu at position 29, and at least one of:
  • the amino acid at position 75 is Ala
  • the amino acid at position 125 is selected from the group consisting of Aa, Cys, Gly, and Thr
  • the amino acid at position 125 is Glu.
  • the amino acid at position 105 is selected from the group consisting of His, Lys, and Arg
  • the amino acid residue at position 104 is Pro
  • the amino acid at position 132, 135, 144 and 161 is Arg
  • the amino acid at position 157 is Asp
  • the amino acid at position 162 and 165 is His.
  • improved alkalophilic mutant TrX xylanases may be constructed through:
  • a precursor plasmid pXYbc which is a pUC type plasmid with a Bacilltus circulans, xylanase gene inserted, has previously been prepared and published (Sung et al, 1993; Campbell et al., U.S. Pat. No. 5,405,769).
  • A. commonly used E. coli strain, HB101 (Clonetech Lab, Palo Alto, Calif.) was used as a transformation and expression host for all gene constructs.
  • Birchwood xylan and Remazol Brilliant Blue R-D-Xylan were purchased from Sigmna (St. Louis, Mo). Hydroxybenzoic acid hydrazide (NOAH) was purchased from Aldrich.
  • Oligonucleotides were prepared with an APPLIED BIOSYSTEM DNA synthesizer (model 380B). All xylanase enzymatic assays were performed in a covered circulating water bath (Haake type P 4391) and maintained within a temperature range of ⁇ 0.1° C.
  • the precursor plasmid pTrX for mutations disclosed below has been previously published (Sung et al, 1995).
  • This plasmid is derived from a pUC 119 plasmid with a synthetic nucleotide sequence encoding a Trichoderma ressei xylanase (TrX; FIG. 2).
  • TrX Trichoderma ressei xylanase
  • FIG. 2 The total assembly of the Trichoderma xylanase gene required two stages, initially for the (92-190; Tr2 numbering) region, then followed by the (1-92; Tr2 numbering) region.
  • the protocol for the construction of this gene is routine and identical to the standard published procedure for many other genes.
  • the protocol requires enzymatic phosphorylation of overlapping synthetic oligonucleotides which encodes a xylanase. This is followed by their ligation into an appropriately cut plasmid.
  • TrX 92-190
  • ten overlapping oligonucleotides see FIG. 2: XyTv-101, SEQ ID NO:29; XyTv-102, SEQ ID NO:30; TrX-103, SEQ ID NO:31; XyTv-104, SEQ ID NO:32; XyTv-105, SEQ ID NO:33; XyTv-106, SEQ ID NO:38; XyTv-107; SEQ ID NO:37; TrX-108, SEQ ID NO:36; XyTv-109, SEQ ID NO:35; and XyTv-110, SEQ ID NO:34
  • Phosphorylation reactions were carried out for 1 h at 37° C. The solutions were then combined and heated to 70° C. for 10 min. After being cooled slowly to room temperature, the combined solutions were added to a mixture of 4 mM ATP (3.5 ⁇ L), EcoRI-HindIII linearized plasmid pUC119 (0.1 pmol), and T4DNA ligase(3.5 ⁇ L) and incubated at 12° C. for 20 h. Aliquots of the ligation mixture were used to transform E. coli HB101 on YT plates (8 g yeast extract, 5 g bacto-tryptone, 5 g NaCl, 15 g of agar in 1 L of water) containing ampicillin (100 mg/L).
  • one of the oligonucleotides for example XyTv-110 (10 pmol, 1 ⁇ L) was phosphorylated with 32 P-ATP (10 ⁇ mol, 3 L) using T4 DNA kinase (1 ⁇ L), 10X kinase buffer (1 ⁇ L), and water (4 ⁇ L) at 37° C. for 1 h.
  • Transformants were selected randomly for hybridization analysis. Colonies were grown on YT plates with ampicillin overnight, and transferred onto nylon filters. They were then denatured with 0.5N NaOH-1.5 M NaCl (10 min) and neutralized with 0.5N Tris-HCl (pH 7.0)-1.5M NaCl (10 min). After ultraviolet irradiation at 254 nm for 8 min the filters were-washed with 6X SSC-0.05% TritonX-100 for 30 min. Cell debris was scraped off completely. After another 30 min. in fresh solution, duplicate filters were transferred individually into separate mixtures of 6X SSC-1% dextran sulphate-0.05% TritonX-100-1X Denhardt's hybridization fluid.
  • the 32 P-labelled probe was added to the filter. After 16 h at 45° C., the filter was washed twice with 6X SSC-0.05% TritonX-100 at room temperature for 5 min. and then at 65° C. for 30 rmin. Positively hybridized clones with the intermediate plasmid pBcX-TrX were identified by auto-radiographic analysis.
  • TrX(1-92; Tr2 numbering) region For the assembly of the TrX(1-92; Tr2 numbering) region to complete the full-length Trichoderma reesei xylanse II gene (TrX), the intermediate plasmid pBcX-TrX was linearized by NheI and KpnI endonucleases to release the DNA insert for BcX(1-83).
  • TrX-1 SEQ ID NO:21; XyTv-2, SEQ ID NO:22; TrX-3, SEQ ID NO:23; XyTv-4, SEQ ID NO:24; XyTv-5, SEQ ID NO:28; TrX-6, SEQ ID NO:27; XyTv-7, SEQ ID NO:26; and TrX-8 SEQ ID NO:25
  • TrX(1-91) sequence were ligated into the linearized plassmid pBcX-TrX (FIG. 2), via the protocol described above.
  • the new plasmid pTrX therefore harbored a synthetic TrX gene (SEQ ID NO:39).
  • cassette mutagenesis involved (i) enzymatic phosphorylation of overlapping synthetic oligonucleotides, (ii) ligation of synthetic oligonucleotides with a linearized plasmid, (iii) transformation of the plasmid into E. coli BB101 competent cells, (iv) identification of mutant transformants via hybridization with the labelled oligonucleotide, and (v) confirmation of the mutation through dideoxy nucleotide sequencing.
  • TrX-HML comprises the native TrX xylanase, along with three mutations at N10H (Asn at position 10 is replaced with His), Y27M and N29L.
  • the first thirty amino acids of the sequence comprising N10H, Y27M and N29L are shown below.
  • Plasmid pTrX(1-113) comprises nucleotides 1-113 of SEQ ID NO:39 (nucleotides 1-113 of TrX) and cannot express an active xylanse. Such transformants are confirmed by the absence of a clearing zone or halo around the transformant colonies on blue xylan plates.
  • the new plasmid pTrX(1-113) was constructed via (i) the removal of the TrX(114-190) coding sequence of pTrX through cutting with restriction enzymes BamHI and BglmI, (ii) ligation of the identical cohesive ends of the linearized plasmid, (iii) transformation into the E.
  • coli HB101 competent cells followed by platting on YT plate (containing 5 g yeast extract, 3 g bacto-tryptone, 5 g NaCl, 15 g of agar in 1 L of water, 1 g Remazol Brilliant Blue R-D-xylan) and ampicillin (100 mg/L), (iv) identification of the mutant transformants through the loss of xylanase activity (absence of a clearing zone or halo around the colonies on the blue xylan plate overnight at 40° C.), and (v) confirmation of the mutation through dideoxy nucleotide sequencing.
  • the protocol for each of these steps was similar to that for gene assembly described above.
  • Plasmid pTrX-HML(1-113) is similar to pTrX(1-113), but contains three mutations at positions 10, 27 and 29 (Tr2 numbering) of N10H, Y27M and N29L (as described above).
  • the plasmid was constructed, with the same protocol as described for pTrX(1-113; see above), in that the sequence encoding the TrX(l 141-190) region was deleted.
  • the pTrX-HML(1-113) plasmid does not express an active xylanse.
  • TrX-75A and TrX-150H comprise the sequence of TrX, with the exception of that the Ser at position 75 was replaced with an Ala residue (S75A) in TrX-75A, and the Leu at position 105 was replaced with a His residue (L105H) in TrX-105H.
  • PCR primers used to create these genetically modified xylanses include:
  • PCR oligonucleotide primers TX-75A-1 69 70 71 72 73 74 75 76 77 78 79 80 81 N G N S Y L A V Y G W S R 5′-T GG G AAT TC A TAC TTA GCC GTC TAT GGC TGG TCT AG (SEQ ID NO:40) EcoRI TX-105H-1 100 101 102 103 104 105 106 107 108 109 110 111 112 113 T G A T K H G E V T S D G S 5′-ACC (SEQ ID NO:41) GGC GCC ACA AAA CAC GGC GAA GTC ACT AGT GAT GGA TCC Kas I
  • Reverse PCR primer TX-C1 comprised: Tx-C1 183 184 185 186 187 188 189 190 ter G S A S I T V S CCA AGG CGA TCA TAA TGT CAC TCG ATT TCT AGA AC T TCG AA C CC-5′ (SEQ ID NO:42) BglI HindIII
  • plasmid pTrX was used as a template for PCR.
  • the reaction solution contained plasmid pTrX DNA (50 ng, 15 ⁇ L), 5 ⁇ L 10-X buffer (100 mM KC1, 100 mM ammonium sulfate, 200 mM Tris-HCl pH 8.8, 40 mM magnesium sulfate, 1% TritonX-100, 100 mg/ml BSA), 5 ⁇ L 5 mM dNTPs, PCR primer TX-75A (25 pmol, 2.5 ⁇ L), and reverse PCR primer TX-Cl (25 pmol, 2.5 ⁇ L) and water (19 ⁇ L).
  • the reaction was covered with paraffin oil (50 ⁇ L) to prevent evaporation.
  • the reaction mixture was pre-warmed to 94° C. without enzyme for 5 min, then the reaction mixture was cooled to 72° C.
  • DNA polymerase (1 ⁇ L, 1U) was added to the reaction mixture.
  • the reaction mixture was incubated in a temperature cycler for 30 cycles of 94° C. for 1 min., 55° C. for 2 min. and then 72° C. for 2 min.
  • the yield of the PCR product was approximately 1 ⁇ g of a 400 bp fragment. This fragment was purified from an agarose gel.
  • PCR product (b) (Table 3-1) was prepared and was linearized with the KasI and HindIII restriction nucleases.
  • the linearized product (b) was ligated to the KasI/HindIII-linearized pTrX plasmid to generate plasmid pTrX-b 105 H comprising full length xylanase with Leu at position 105 replaced with His (L105H).
  • TrX-HML-105H, pTrX-HM;-105K and pTrX-HML-105R are similar to TrX-HML except that Leu at position 105 is replaced by His (L105H), Lys (L105K) and Arg (L105R), respectively.
  • TrX-HML xylanse is similar to the TrX xylanse except that Asn at position 10 is replaced with His (N OH), Tyr at position 27 is replaced by Met (Y27M) and Asn at position 29 is replaced by Leu (N29L).
  • a similar PCR product (b) for the synthesis of pTrX-b 105 H was used for the construction of pTrX-HML-105H.
  • the PCR primers with mutation (in bold type) in the construction of pTrX-HML-105K and pTrX-HML-105R are shown below.
  • TrX-HML-75A and TrX-HML-75A-105H are similar to TrX-HML except that Ser at position 75 is replaced by Ala (S75A) in TrX-HML-75A construct, and in TrX-HM-75A-105H Ser at position 75 is replaced by Ala (S75A) and Leu at position 105 is replaced by His (L105H).
  • TrX-HML-75A-105R, TrX-HML-75C-105R, TrX-HML-75G-105R and TrX-HML-75T-105R are similar to TrX-HML-105R (comprising mutations N10H, Y27M, N29L and L105R), with the exception of an additional single mutation S75A, S75C, S75G and S75T in each of the mutant xylanses, respectively.
  • TrX-E125A and TrX-HML-125A129E were identical to TrX-HML, with the exception of additional mutations Q125A and I129E.
  • the intact mutant genes were assembled via the ligation of two DNA sequences encoding the 1-121 and the 122-190 regions.
  • the DNA sequence encoding the 1-121 region was created via deletion of the plasmid pTrX-HML by nucleases NheI and MluI.
  • the DNA sequence encoding the 122-190 region was generated via PCR.
  • the PCR primers with mutation Q125A or Q125A/I129E are shown below.
  • TX-125A-1 120 121 122 123 124 125 126 127 128 129 130 131 132 133 Q R V N A P S I I G T A T 5′-C CAA CGC GTT AAT GCG CCA TCG ATC ATT GGA ACC GCC ACC (SEQ ID NO:48) MluI TX-125A129E1 120 121 122 123 124 125 125 127 128 129 130 131 132 133 Q R V N A P S I E G T A T 5′-C CA A CGC GT T AAT GCG CCA TCG ATC GAG GGA ACC GCC ACC (SEQ ID NO:49) MluI
  • TrX-HML-75G-105R-125A129E was identical to TrX-HML-75G-105R, with the exception of the additional mutations Q125A and I129E.
  • the intact mutant genes were assembled via the ligation of two DNA sequences encoding the 1-121 and the 122-190 regions.
  • the DNA sequence encoding the 1-121 region prepared through the deletion of plasmid pTrX-HML-75G-105R with restriction nucleases listed below (Table 3-6). TABLE 3-6 Restriction enzymes for IPCR Deletion sequence Precursor plasmid product (A) pTrX-HML-75G-105R NheI/MluI
  • the DNA sequence encoding the 122-190 region was the same MluI/HindIII-cut PCR product (k) in the Example 1.9 (above).
  • 1.11 Construction of the plasmids pTrX-HML-75G-105H-125A129E, pTrX-HML-75A-105H-125A129E and pTrX-HML-75A-105R-125A129E.
  • TrX-HML-75G-105H-125A129E, pTrX-HML-75A-105H-125A129E and pTrX-HML 75A-105R-125A129E were identical to TrX- 75G-105R-125A129E, with the exception of the appropriate mutations at residues-75 (S75A or S75G) and -105 (L105H or L105R).
  • the intact mutant genes were assembled via the ligation of two DNA sequences encoding the 1-101 and the 102-190 regions.
  • TrX-HML-75G-104P105H-125A129E and pTrX-HML-75G-104P105R-125A129E were identical to TrX-HMl-75G-105H-125A129E and TrX-HML-75G-105R-125A129E respectively, with the exception of an additional mutation of Lys-104 into proline (K104P).
  • the intact mutant genes were assembled via the ligation of two DNA sequences encoding the 1-101 and the 102-190 regions.
  • the DNA sequence encoding the 1-101 region for the three new mutants was the same deletion sequence (B) through the cutting of plasmid pTrX-HML-75G-105R by nucleases NheI and KasI in the Example 1.11 (above).
  • mutants pTrX-157D-161R-162H-165H; pTrX-HML-75A-105H-125A-129E-132R-135R;
  • the culture conditions comprised a 5 ml culture of overnight innoculant in 2YT medium (16 g bacto-tryptone, 10 g yeast extract, 5 g NaCl, 1 L of water) containing ampicillin (100 mg/L) was added to 2YT medium (1 L) with ampicillin. The cultures were grown with shaking (200 rpm) at 37° C. After 16 hr, cells were harvested.
  • Protein samples were prepared from cells by first making an extract of the cells by grinding 10 g of the cell paste with 25 g of alumina powder. After grinding to smooth mixture, small amounts (5 ml) of ice cold buffer A (10 nM sodium acetate, pH 5.5 for BcX mutants) or buffer B (10 mM sodium acetate, pH 4.6 for TX mutants) were added and the mixture ground vigorously between additions. The alumina and cell debris were removed by centrifugation of the mixture at 8000 x g. for 30 min.
  • buffer A 10 nM sodium acetate, pH 5.5 for BcX mutants
  • buffer B 10 mM sodium acetate, pH 4.6 for TX mutants
  • the xylanse sample was pumped onto a 50 ml bed volume, CM-sepharose fast flow, cation exchange column (Pharmacia Biotech, Uppsala), equilibrated in 10 mM sodium acetate (pH 4.6).
  • the xylanse was eluted with a 250 ml linear gradient (0 to 0.6M NaCl in 10 mM sodium acetate, pH 4.6) at a flow rate of 1 ml/min.
  • the xylanses elute at 150 to 200 ml of the gradient.
  • the quantitative assay determined the number of reducing sugar ends generated from soluble xylan.
  • the substrate for this assay was the fraction of birchwood xylan which dissolved in water from a 5% suspension of birchwood xylan (Sigma Chemical Co.). After removing the insoluble fraction, the supernatant was freeze dried and stored in a desiccator.
  • the assay procedure was similar to the standard assay with changes in the incubation temperature and time.
  • the xylanases (15 ⁇ g/mL) and soluble xylan substrate, in 50 mM sodium citrate buffer of pH 5.5, were mixed and incubated in a circulating water bath at different temperatures. After a 30 min incubation, the amount of reducing sugars released from xylan was determined by HBAH analysis and was calculated as a relative activity, with the value at 40° C. representing 100%.
  • TrX-HML xylanase Mutation of Leu 105 to His (L105H) in TrX-HML xylanase to produce the TrX-HML-105H mutant xylanase also exhibited increased enzymatic activity over the parent TrX-HML xylanase at 70 and 75° C. (FIG. 4).
  • TrX-HML-75A-105H xylanase exhibited a maximum enzymatic activity at a temperature of 70° C. and further showed greater enzymatic activity than either TrX-75A or TrX-HML105H single mutant xylanases at 70° C. (FIG. 4).
  • TrX-157D-161R-162H-165H was neutral with respect to, or resulted in a slight increase in, the thermophilicity of this enzyme over that of the parent TrX enzyme (FIG. 15).
  • TrX-HML xylanses bearing mutations at position-105 were constructed to determine those amino acid residues which enhance the thermophilicity of the parent TrX-HML enzyme (FIG. 5).
  • Three mutants at position 105, TrX-HML-105H, TrX-HML-105R and TrX-HML-105K showed greater enzymatic activity than the precursor TrX-HML enzyme at 70° C. or higher.
  • the three mutations involve substituting Leu at position 105, a relatively hydrophobic branched-chain amino acid with His, Arg and Lys, amino acid residues that are hydrophilic or positively charged or basic. Such mutations enhanced the thermophilicity of the mutant xylanases.
  • TrX-H75A-105R xylanse showed a similar temperature-activity profile to TrX-HML-75A-105H xylanse, suggesting that the S75A and L105R mutations, like the effect of the S75A and L105H are additive or complementary. These results further suggest that basic residues at position 105 enhance the thermophilicity of the xylanases.
  • TrX-HML-105R position-75 of TrX-HML-105R was mutated to determine those residues which exhibited enhanced thermophilicity (FIG. 6).
  • Three genetically modified xylanase mutants, TrX-HML-75C-105R, TrX-HML-75A-105R and TrX-HML-75G-105R showed greater enzymatic activity than either the precursor TrX-HML-1 05R xylanse or the TrX-HML xylanse at temperatures greater than 60° C.
  • TrX-75T-105R xylanse showed no enhancement in thermophilicity over the precursor TrX-HML-105R xylanse that has a natural Ser residue at position 75.
  • the mutant threonine residue at position 75 is a hydrophilic amino acid.
  • the mutations which involve replacing Ser, a polar amino acid at position 75 with small, nonpolar amino -acids, such as but not wishing to be limiting Ala, Gly or Cys lead to an increase in the thermophilicity of the xylanase.
  • the amount of reducing sugars released from the xylan substrate was determined by HBAH analysis and the enzymatic activity as a function of pH was calculated for a variety of mutant xylanases with the maximal activity taken as 100%.
  • TrX-75A xylanase The effect of pH conditions on the enzymatic activity of single mutant TrX-75A xylanase is shown in FIG. 10.
  • the TrX-75A mutant xylanase displayed maximum activity at a pH which was higher (pH 5.5) than the pH at which the native TrX enzyme exhibits maximum activity (pH 5.0).
  • An increase in enzymatic activity was also exhibited by the mutant in comparison to the natural TrX xylanase at-pH conditions of 6.0 and 6.5.
  • Trx-75A A similar contribution to improved alkalophilicity by the S75A in Trx-75A was also observed for the TrX-HML-75A over the parent TrX-hML xylanase at pH conditions between 6.5 and-7 (FIG. 11).
  • TrX-HML-105H mutant xylanase also increased the enzymatic activity over the parent TrX-HML xylanase at pH 6.5 and 7.0 FIG. 11).
  • the combination mutant TrX-HML-75A-105H xylanase showed greater enzymatic activity than either TrX-HML-75A or TrX-HML-105H single mutant xylanases at pH 6.5 and 7.0 (FIG. 11), suggesting that the effects of the S75A mutation and the L105H mutation on the alkalophilicity of the xylanase are additive or complementary.
  • a series of genetically modified xylanases modified at position 105 were constructed to determine those residues which promote increased alkalophilicity in modified xylanses (FIG. 12).
  • Three mutant xylanases bearing three mutations at position 75, TrX-HML-105H, TrX-HML-105R and TrX-HML-105K showed greater enzymatic activity than the precursor TrX-HML xylanse at pH conditions of 6.5 and 7.0.
  • the mutations which lead to increases in alkalophilicity represent a change from a branched chain relatively hydrophobic Leu residue to a residue which is hydrophilic, positively charged or basic.
  • the hydrophilic, positively charged, or basic residues may facilitate intramolecular packing with other atoms that are juxtapositioned in the same vicinity in the tertiary structure of the xylanse. These residues may stabilize the three dimensional structure of the enzyme against structural perturbations in the molecule which may arise via the titration of several ionizable side-chains of amino aids in other regions of the molecule.
  • the basic ionized form of the side chain may be important in altering the pH activity profile of the enzyme, as at pH conditions between 6 and 7, Arg and Lys residues have side-chains which likely remain protonated.
  • His residues having a pKa of approximately 6 in solution for its imidazole moiety could be present in either a protonated or unprotonated form.
  • the polarity of the substituents surrounding an amino acid side chain may affect its pKa value.
  • the side chain of a His residue in a polar or hydrophobic region of a protein may exhibit a pKa of 6 whereas the same side-chain in a hydrophobic or apolar environment may exhibit a pKa of 7 or greater.
  • TrX-HML-AHAE-RR-DRHH, or TrX-HML-AHAE-RRR-DRRH each exhibited an increase in alkalophilicity (FIGS. 18 and 19).
  • These enzymes are also characterized as exhibiting a MEP of about pH 7.0 (FIGS. 18 and 19).
  • TrX- AML A-RR-DRHH (FIGS. 18 and 19).
  • the MEP of TrX-HNEL-AIA-RR-DRHH is about pH 7.4 FIGS. 18 and 19).
  • residues may comprise Gly, Ala, and-Cys; ii) mutation of Ser 75 to Thr; iii) mutation of Leu 105 to a basic residue such as but not limited to Arg, Lys or His; iv)mutation of Ala 132, Tyr 135, His 144, Gln 161, Gln 162, Thr 165 or a combination thereof to a basic amino acid, for example but not limited to, Arg, Lys or His; v) mutation of Asn157 to an acidic amino acid Asp or Glu, or vi) combination of mutations described in i) or ii) with those described in iii) and iv) for the improvement of alkalophilicity.
  • mutant xylanases which exhibit improved thermophilicity and alkalophilicity and the benefits associated with these enzymes in the production of paper pulp
  • these mutant xylanases may also be of use in other industrial processes, for example but not limited to the washing of precision devices and semiconductors.
  • the mutant xylanses may be used in chemical processes that employ small quantities of denaturants or detergents or in the presence of solvents, for example but not limited to small amounts of apolar solvents such as but not limited to hexane, dioxanes, carbontetrachloride, benzene, ethers, chloroform, acetic acid and methylene chloride, and polar solvents such as but not limited to acetone, alcohols, dimethylformamide, acetonitrile, sulfolane, dimethylsulfoxide and water.
  • apolar solvents such as but not limited to hexane, dioxanes, carbontetrachloride, benzene, ethers, chloroform, acetic acid and methylene chloride
  • polar solvents such as but not limited to acetone, alcohols, dimethylformamide, acetonitrile, sulfolane, dimethylsulfoxide and water.
  • Wakarchuck W. W. Sung, W. L., Campbell, R. L., Cunningham, A., Watson, D. C. and Yaguchi, M. (1994) Protein Engineerng 7:1379-1386.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Paper (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
US10/307,441 2000-05-31 2002-12-02 Modified xylanases exhibiting increased thermophilicity and alkalophilicity Abandoned US20030166236A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/377,644 US7695947B2 (en) 2000-05-31 2006-03-17 Modified xylanases exhibiting increased thermophilicity and alkalophilicity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21380300P 2000-05-31 2000-05-31
PCT/CA2001/000769 WO2001092487A2 (en) 2000-05-31 2001-05-31 Modified xylanases exhibiting increased thermophilicity and alkalophilicity

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2001/000769 Continuation WO2001092487A2 (en) 2000-05-31 2001-05-31 Modified xylanases exhibiting increased thermophilicity and alkalophilicity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/377,644 Division US7695947B2 (en) 2000-05-31 2006-03-17 Modified xylanases exhibiting increased thermophilicity and alkalophilicity

Publications (1)

Publication Number Publication Date
US20030166236A1 true US20030166236A1 (en) 2003-09-04

Family

ID=22796573

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/307,441 Abandoned US20030166236A1 (en) 2000-05-31 2002-12-02 Modified xylanases exhibiting increased thermophilicity and alkalophilicity
US11/377,644 Expired - Fee Related US7695947B2 (en) 2000-05-31 2006-03-17 Modified xylanases exhibiting increased thermophilicity and alkalophilicity

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/377,644 Expired - Fee Related US7695947B2 (en) 2000-05-31 2006-03-17 Modified xylanases exhibiting increased thermophilicity and alkalophilicity

Country Status (7)

Country Link
US (2) US20030166236A1 (fi)
AU (1) AU2001267171A1 (fi)
BR (1) BR0111316A (fi)
CA (1) CA2410917C (fi)
FI (1) FI120697B (fi)
SE (1) SE525279C2 (fi)
WO (1) WO2001092487A2 (fi)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077071A1 (en) * 2001-01-18 2004-04-22 Tolan Jeffrey S. Methods of xylanase treatment in bleaching
US20050150619A1 (en) * 2002-03-06 2005-07-14 Iogen Bio-Products Corporation Xylanase treatment of chemical pulp
WO2007115407A1 (en) * 2006-04-12 2007-10-18 National Research Council Of Canada Modification of xylanases to increase thermophilicity, thermostability and alkalophilicity
US20090075330A1 (en) * 2001-11-21 2009-03-19 Sung Wing L Xylanases with enhanced thermophilicity and alkalophilicity
JP2017148044A (ja) * 2007-10-03 2017-08-31 ビーピー・コーポレーション・ノース・アメリカ・インコーポレーテッド キシラナーゼ、キシラナーゼをコードする核酸並びにそれらを製造及び使用する方法
WO2023014081A1 (ko) * 2021-08-06 2023-02-09 씨제이제일제당 (주) 자일라나제 활성을 갖는 변이형 폴리펩티드

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003251549B2 (en) * 2002-06-14 2008-03-13 Bp Corporation North America Inc. Xylanases, nucleic acids encoding them and methods for making and using them
EP1727903B1 (en) 2004-03-25 2011-10-05 Iogen Bio-Products Corporation Modified xylanases exhibiting improved expression
RU2464313C2 (ru) * 2006-04-12 2012-10-20 Нэйшенл Рисерч Каунсил Оф Кэнэда Модифицированная ксиланаза
US8623629B2 (en) 2008-12-23 2014-01-07 Dupont Nutrition Biosciences Aps Polypeptides with xylanase activity
CA3012382C (en) 2011-11-25 2020-08-18 Mitsui Chemicals, Inc. Mutant xylanase, manufacturing method and use therefor, and method for manufacturing saccharified lignocellulose
CN103627686B (zh) * 2013-11-14 2015-03-18 青岛蔚蓝生物集团有限公司 一种木聚糖酶突变体及其应用
EP3149028B1 (en) 2014-05-30 2021-09-15 Novozymes A/S Variants of gh family 11 xylanase and polynucleotides encoding same
GB2567010A (en) 2017-10-02 2019-04-03 Univ Strathclyde Apparatus for the rehabilitation, assistance and/or augmentation of arm strength in a user
CN109971738B (zh) * 2017-12-28 2020-09-04 中粮集团有限公司 木聚糖酶AnXyn10C的T32R突变体及其制备方法和用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078802A (en) * 1987-12-12 1992-01-07 Nikko Bio Technica Co., Ltd. Method of washing super precision devices, semiconductors, with enzymes
US5405769A (en) * 1993-04-08 1995-04-11 National Research Council Of Canada Construction of thermostable mutants of a low molecular mass xylanase
US5759840A (en) * 1996-09-09 1998-06-02 National Research Council Of Canada Modification of xylanase to improve thermophilicity, alkalophilicity and thermostability
US6682923B1 (en) * 1999-05-12 2004-01-27 Xencor Thermostable alkaliphilic xylanase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018426D0 (en) 1990-08-22 1990-10-03 Sandoz Ltd Improvements in or relating to novel compounds
EP0728197A1 (en) 1993-11-05 1996-08-28 Cornell Research Foundation, Inc. THERMOSTABLE XYLANASE FROM A $i(THERMOMONOSPORA FUSCA) GENE
JP3435946B2 (ja) * 1994-12-21 2003-08-11 王子製紙株式会社 耐熱性キシラナーゼ
ATE344837T1 (de) 1998-11-16 2006-11-15 Ca Nat Research Council Hitzestabile xylanasen
US7510860B1 (en) * 2001-11-21 2009-03-31 National Research Council Of Canada Xylanases with enhanced thermophilicity and alkalophilicity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5078802A (en) * 1987-12-12 1992-01-07 Nikko Bio Technica Co., Ltd. Method of washing super precision devices, semiconductors, with enzymes
US5405769A (en) * 1993-04-08 1995-04-11 National Research Council Of Canada Construction of thermostable mutants of a low molecular mass xylanase
US5759840A (en) * 1996-09-09 1998-06-02 National Research Council Of Canada Modification of xylanase to improve thermophilicity, alkalophilicity and thermostability
US5866408A (en) * 1996-09-09 1999-02-02 National Research Council Of Canada Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
US6682923B1 (en) * 1999-05-12 2004-01-27 Xencor Thermostable alkaliphilic xylanase

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077071A1 (en) * 2001-01-18 2004-04-22 Tolan Jeffrey S. Methods of xylanase treatment in bleaching
US7320741B2 (en) 2001-01-18 2008-01-22 Iogen Bio-Products Corporation Method of xylanase treatment in a chlorine dioxide bleaching sequence
US20090075330A1 (en) * 2001-11-21 2009-03-19 Sung Wing L Xylanases with enhanced thermophilicity and alkalophilicity
US7510860B1 (en) * 2001-11-21 2009-03-31 National Research Council Of Canada Xylanases with enhanced thermophilicity and alkalophilicity
US20050150619A1 (en) * 2002-03-06 2005-07-14 Iogen Bio-Products Corporation Xylanase treatment of chemical pulp
US7368036B2 (en) * 2002-03-06 2008-05-06 Iogen Bio-Products Corporation Xylanase treatment of chemical pulp
WO2007115407A1 (en) * 2006-04-12 2007-10-18 National Research Council Of Canada Modification of xylanases to increase thermophilicity, thermostability and alkalophilicity
US20090148923A1 (en) * 2006-04-12 2009-06-11 Sung Wing L Modification of xylanases to increase thermophilicity, thermostability and alkalophilicity
US8927248B2 (en) 2006-04-12 2015-01-06 National Research Council Canada Modification of xylanases to increase thermophilicity, thermostability and alkalophilicity
CN101460615B (zh) * 2006-04-12 2015-04-29 加拿大国家研究委员会 提高木聚糖酶嗜热性、热稳定性和嗜碱性的修饰
JP2017148044A (ja) * 2007-10-03 2017-08-31 ビーピー・コーポレーション・ノース・アメリカ・インコーポレーテッド キシラナーゼ、キシラナーゼをコードする核酸並びにそれらを製造及び使用する方法
WO2023014081A1 (ko) * 2021-08-06 2023-02-09 씨제이제일제당 (주) 자일라나제 활성을 갖는 변이형 폴리펩티드

Also Published As

Publication number Publication date
SE0203555D0 (sv) 2002-12-02
US20090325267A1 (en) 2009-12-31
WO2001092487A3 (en) 2002-09-26
CA2410917A1 (en) 2001-12-06
SE525279C2 (sv) 2005-01-25
CA2410917C (en) 2012-11-27
WO2001092487A2 (en) 2001-12-06
WO2001092487A9 (en) 2002-12-05
SE0203555L (sv) 2003-01-29
BR0111316A (pt) 2003-12-16
US7695947B2 (en) 2010-04-13
FI120697B (fi) 2010-01-29
FI20022120A (fi) 2002-12-02
AU2001267171A1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
US7695947B2 (en) Modified xylanases exhibiting increased thermophilicity and alkalophilicity
EP0828002B1 (en) Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
US8927248B2 (en) Modification of xylanases to increase thermophilicity, thermostability and alkalophilicity
Georis et al. Purification and properties of three endo-β-1, 4-xylanases produced by Streptomyces sp. strain S38 which differ in their ability to enhance the bleaching of kraft pulps☆
AU775311B2 (en) Thermostable xylanases
Benech et al. Recombinant expression, characterization, and pulp prebleaching property of a Phanerochaete chrysosporium endo-β-1, 4-mannanase
CA2435527C (en) Xylanases with enhanced thermophilicity and alkalophilicity
NO323549B1 (no) Termostabile xylanaser, isolert og renset DNA-sekvens, vektor, mikrobevertscelle, isolert mikroorganisme, fremgangsmate for fremstilling av en xylanase, for nedbryting av xylan og for delignifiering av tremasse, samt blanding og anvendelse av xylanase.
US7060482B1 (en) Thermostable xylanases
Georis et al. Sequence, overproduction and purification of the family 11 endo-β-1, 4-xylanase encoded by the xyl1 gene of Streptomyces sp. S38
WO2006104448A1 (en) Thermostable alkaline xylanase

Legal Events

Date Code Title Description
AS Assignment

Owner name: NATIONAL RESEARCH COUNCIL OF CANADA, CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUNG, WING L.;REEL/FRAME:013836/0630

Effective date: 20030115

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION